Total Payments
$4,234
2024 Payments
$800.05
Companies
40
Transactions
221
Medicare Patients
413
Medicare Billing
$35,766
Payment Breakdown by Category
Food & Beverage$3,991 (94.3%)
Education$243.31 (5.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,991 | 211 | 94.3% |
| Education | $243.31 | 10 | 5.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $611.11 | 34 | $0 (2024) |
| Astellas Pharma US Inc | $518.73 | 25 | $0 (2024) |
| Myovant Sciences Inc. | $321.70 | 21 | $0 (2022) |
| Novo Nordisk Inc | $306.48 | 18 | $0 (2024) |
| Sumitomo Pharma America, Inc. | $251.52 | 12 | $0 (2024) |
| Aspira Women's Health Inc | $224.50 | 4 | $0 (2023) |
| AMAG Pharmaceuticals, Inc. | $182.31 | 9 | $0 (2019) |
| Covidien LP | $157.72 | 5 | $0 (2020) |
| Lilly USA, LLC | $149.37 | 5 | $0 (2024) |
| Hologic, LLC | $144.11 | 11 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $800.05 | 38 | Astellas Pharma US Inc ($167.88) |
| 2023 | $784.17 | 29 | Astellas Pharma US Inc ($261.48) |
| 2022 | $778.84 | 45 | Myovant Sciences Inc. ($277.68) |
| 2021 | $328.96 | 20 | AbbVie Inc. ($97.72) |
| 2020 | $309.24 | 18 | AbbVie Inc. ($75.76) |
| 2019 | $622.96 | 32 | Novo Nordisk Inc ($177.62) |
| 2018 | $263.04 | 15 | AMAG Pharmaceuticals, Inc. ($99.86) |
| 2017 | $346.70 | 24 | AMAG Pharmaceuticals, Inc. ($62.57) |
All Payment Transactions
221 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/21/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $26.81 | General |
| Category: UROLOGY | ||||||
| 11/14/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $14.24 | General |
| Category: Biological | ||||||
| 10/22/2024 | COLOPLAST CORP | Altis (Device) | Food and Beverage | In-kind items and services | $25.83 | General |
| Category: Women's Health | ||||||
| 10/17/2024 | ABBVIE INC. | LILETTA (Drug) | Food and Beverage | In-kind items and services | $17.75 | General |
| Category: WOMENS HEALTH | ||||||
| 10/10/2024 | Exeltis, USA Inc. | SLYND (Drug) | Food and Beverage | In-kind items and services | $19.22 | General |
| Category: CONTRACEPTIVE | ||||||
| 10/07/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $13.61 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 10/01/2024 | CooperSurgical, Inc. | Endosee (Device) | Food and Beverage | In-kind items and services | $18.22 | General |
| Category: Obstetrics/Gynecology (Women's Health) | ||||||
| 09/12/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $17.55 | General |
| Category: Biological | ||||||
| 08/01/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $19.41 | General |
| Category: Biological | ||||||
| 07/30/2024 | ABBVIE INC. | LILETTA (Drug) | Food and Beverage | In-kind items and services | $16.72 | General |
| Category: WOMENS HEALTH | ||||||
| 07/25/2024 | Intra-Sana Laboratories | RELTONE 200 MG (Drug), GLYCATE, RELTONE 400 MG | Food and Beverage | In-kind items and services | $24.09 | General |
| Category: GALLSTONES | ||||||
| 07/25/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $8.43 | General |
| Category: Biological | ||||||
| 07/24/2024 | Sumitomo Pharma America, Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $28.01 | General |
| Category: HORMONE THERAPY | ||||||
| 07/24/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $14.17 | General |
| Category: Obesity | ||||||
| 06/27/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $19.23 | General |
| Category: Biological | ||||||
| 06/25/2024 | Sumitomo Pharma America, Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $28.01 | General |
| Category: HORMONE THERAPY | ||||||
| 05/30/2024 | Lilly USA, LLC | ZEPBOUND (Drug) | Food and Beverage | In-kind items and services | $12.96 | General |
| Category: Obesity | ||||||
| 05/30/2024 | Lilly USA, LLC | ZEPBOUND (Drug) | Food and Beverage | In-kind items and services | $0.23 | General |
| Category: Obesity | ||||||
| 05/29/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $20.17 | General |
| Category: Biological | ||||||
| 05/15/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $22.66 | General |
| 04/24/2024 | MAYNE PHARMA COMMERCIAL LLC | — | Food and Beverage | In-kind items and services | $33.86 | General |
| 04/22/2024 | Sumitomo Pharma America, Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $29.80 | General |
| Category: HORMONE THERAPY | ||||||
| 04/18/2024 | Axonics, Inc. | Axonics (Device) | Food and Beverage | In-kind items and services | $17.50 | General |
| Category: Urology | ||||||
| 04/03/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $11.74 | General |
| Category: Biological | ||||||
| 03/29/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $8.13 | General |
| Category: Biological | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 117 | 142 | $24,042 | $11,110 |
| 2022 | 6 | 119 | 142 | $24,802 | $10,921 |
| 2021 | 5 | 81 | 91 | $15,930 | $7,513 |
| 2020 | 6 | 96 | 108 | $14,232 | $6,221 |
Total Patients
413
Total Services
483
Medicare Billing
$35,766
Procedure Codes
23
All Medicare Procedures & Services
23 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 42 | 55 | $9,625 | $5,291 | 55.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 17 | 21 | $2,625 | $1,559 | 59.4% |
| 76830 | Ultrasound scan of uterus, ovaries, tubes, cervix and pelvic area through vagina | Office | 2023 | 13 | 17 | $4,250 | $1,477 | 34.7% |
| 76856 | Complete ultrasound scan of pelvis | Office | 2023 | 13 | 17 | $4,250 | $1,426 | 33.5% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2023 | 18 | 18 | $2,340 | $741.24 | 31.7% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2023 | 14 | 14 | $952.00 | $616.70 | 64.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 31 | 48 | $8,400 | $4,529 | 53.9% |
| 76830 | Ultrasound scan of uterus, ovaries, tubes, cervix and pelvic area through vagina | Office | 2022 | 20 | 21 | $5,250 | $1,854 | 35.3% |
| 76856 | Complete ultrasound scan of pelvis | Office | 2022 | 21 | 22 | $5,500 | $1,801 | 32.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 18 | 22 | $2,750 | $1,491 | 54.2% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2022 | 15 | 15 | $1,950 | $624.42 | 32.0% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2022 | 14 | 14 | $952.00 | $621.95 | 65.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 26 | 32 | $5,600 | $3,230 | 57.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 17 | 20 | $2,500 | $1,363 | 54.5% |
| 76830 | Ultrasound pelvis through vagina | Office | 2021 | 11 | 12 | $3,000 | $1,240 | 41.3% |
| 76856 | Ultrasound of pelvis, complete, not pregnancy related | Office | 2021 | 11 | 11 | $2,750 | $1,013 | 36.8% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2021 | 16 | 16 | $2,080 | $667.20 | 32.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 23 | 28 | $3,864 | $2,180 | 56.4% |
| 76856 | Ultrasound of pelvis | Office | 2020 | 14 | 16 | $3,412 | $1,244 | 36.4% |
| 76830 | Ultrasound pelvis through vagina | Office | 2020 | 14 | 16 | $3,400 | $1,157 | 34.0% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 17 | 20 | $1,820 | $1,082 | 59.4% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2020 | 12 | 12 | $1,560 | $504.41 | 32.3% |
| 81002 | Urinalysis, manual test | Office | 2020 | 16 | 16 | $176.00 | $55.05 | 31.3% |
About Dr. Ginger Connor, MD
Dr. Ginger Connor, MD is a Gynecology healthcare provider based in Lake Orion, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/14/2007. The National Provider Identifier (NPI) number assigned to this provider is 1407061179.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ginger Connor, MD has received a total of $4,234 in payments from pharmaceutical and medical device companies, with $800.05 received in 2024. These payments were reported across 221 transactions from 40 companies. The most common payment nature is "Food and Beverage" ($3,991).
As a Medicare-enrolled provider, Connor has provided services to 413 Medicare beneficiaries, totaling 483 services with total Medicare billing of $35,766. Data is available for 4 years (2020–2023), covering 23 distinct procedure/service records.
Ad
Practice Information
- Specialty Gynecology
- Location Lake Orion, MI
- Active Since 05/14/2007
- Last Updated 11/18/2014
- Taxonomy Code 207VG0400X
- Entity Type Individual
- NPI Number 1407061179
Products in Payments
- MYFEMBREE (Drug) $530.92
- Veozah (Drug) $365.28
- OVA1 (Device) $240.32
- Saxenda (Drug) $210.31
- INTRAROSA (Drug) $182.31
- LO LOESTRIN FE (Drug) $165.00
- TruClear (Device) $157.72
- ZEPBOUND (Drug) $149.37
- CONTRAVE (Drug) $133.58
- SLYND (Drug) $131.62
- LILETTA (Drug) $121.74
- ORILISSA (Drug) $105.47
- ZULRESSO (Drug) $102.80
- ORIAHNN (Drug) $102.73
- Phexxi (Drug) $96.10
- Orilissa (Drug) $74.06
- SOLOSEC (Drug) $72.97
- Osphena (Drug) $57.03
- Altis (Device) $49.95
- Myrbetriq (Drug) $48.79
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.